Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Exploratory Study to Assess the Safety, Tolerability and Clinical Activity of Topically Applied ESBA105 in Patients With Acute Anterior Uveitis

NCT00823173 is registered in ClinicalTrials.gov with ESBATech AG as lead sponsor.

NCT NCT00823173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00823173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Exploratory Study to Assess the Safety, Tolerability and Clinical Activity of Topically Applied ESBA105 in Patients With Acute Anterior Uveitis
Lead sponsor
ESBATech AG
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2010
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anterior uveitis